Veterinary Medicines

Furosoral 40 mg tablets for dogs and cats

Authorised
  • Furosemide
Download as PDF

Product identification

Medicine name:
Furosoral 40 mg tablets for dogs and cats
Furosoral vet 40 mg tabletter til katt og hund
Active substance:
  • Furosemide
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Furosemide
    40.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC03CA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Norway
Package description:
  • Cardboard box of 5 Aluminium-PVDC/PVC blisters with 10 tablets each
  • Cardboard box of 100 Aluminium-PVDC/PVC blisters with 10 tablets each. Cardboard box containing 10 separate cardboard boxes, each containing 1 blister of 10 tablets
  • Cardboard box of 10 Aluminium-PVDC/PVC blisters with 10 tablets each. Cardboard box containing 10 separate cardboard boxes, each containing 1 blister of 10 tablets
  • Cardboard box of 2 Aluminium-PVDC/PVC blisters with 10 tablets each
  • Cardboard box of 25 Aluminium-PVDC/PVC blisters with 10 tablets each. Cardboard box containing 10 separate cardboard boxes, each containing 1 blister of 10 tablets
  • Cardboard box of 7 Aluminium-PVDC/PVC blisters with 10 tablets each
  • Cardboard box of 6 Aluminium-PVDC/PVC blisters with 10 tablets each
  • Cardboard box of 50 Aluminium-PVDC/PVC blisters with 10 tablets each. Cardboard box containing 10 separate cardboard boxes, each containing 1 blister of 10 tablets.
  • Cardboard box of 4 Aluminium-PVDC/PVC blisters with 10 tablets each
  • Cardboard box of 3 Aluminium-PVDC/PVC blisters with 10 tablets each
  • Cardboard box of 1 Aluminium-PVDC/PVC blister with 10 tablets
  • Cardboard box of 8 Aluminium-PVDC/PVC blisters with 10 tablets each
  • Cardboard box of 9 Aluminium-PVDC/PVC blisters with 10 tablets each

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Le Vet. Beheer B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Artesan Pharma GmbH & Co. KG
  • Lelypharma B.V.
  • Genera d.d.
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 14-10174
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0192/002
Concerned member states:
  • Austria
  • Belgium
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 27/01/2022
Download

Combined File of all Documents

English (PDF)
Published on: 22/01/2024
Download